OCEAN Dx receives €202k non-dilutive funding from Region Nouvelle-Aquitaine to create its first product prototype.

Ocean Dx receives €202k non dilutive funding from Region Nouvelle-Aquitaine
by OCEAN Dx | 17 July 2020
Category
New Posts
- ESCMID Global 2026
- 9th Annual Meeting of the European Sepsis Alliance
- Sepsis Alliance Symposium 2026 – Diagnostics and Diagnostic Stewardship
- The 5-Hour Sepsis Test: No Cultures Required – The Pathologist, 4th February 2026
- OCEAN Dx Achieves, in collaboration with Bordeaux University Hospital, Breakthrough in Rapid Sepsis Diagnosis with Clinical Results Matching Gold Standard
OCEAN Dx is an In Vitro Diagnostic company.
Our goal is to offer revolutionary diagnostic tests for infectious diseases.